Live Breaking News & Updates on Duopharma Biotech Berhad Group

Stay updated with breaking news from Duopharma biotech berhad group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MOH inks term sheet agreements with two vaccine suppliers


MOH inks term sheet agreements with two vaccine suppliers
26 Jan 2021 / 21:35 H.
KUALA LUMPUR: The Ministry of Health (MOH) today signed term sheet agreements with two vaccine suppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd for the procurement of 18.4 million doses of Covid-19 vaccine for 28.75 per cent of the Malaysian population.
MOH, in a statement today said PLS would supply 12 million doses of Covid-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated produced by Sinovac Life Science Co. Ltd, which would be distributed in stages beginning April.
“Duopharma will supply 6.4 million doses of Sputnik V vaccine, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine is expected to be distributed in stages by end-March 2021,” it said. ....

Kuala Lumpur , Abdul Shatar , Duopharmam Sdn Bhd , Adham Baba , Pharmaniaga Lifescience Sdn Bhd , Drug Control Authority , Duopharma Biotech Berhad Group , Ministry Of Health , Immunisation Programme , Gamaleya Research Institute Of Epidemiology , National Covid , National Pharmaceutical Regulatory Division , Sinovac Life Science Co , Sdn Bhd , Vero Cell , Sinovac Life Science , Gamaleya Research Institute , Minister Datuk Seri Dr Adham Baba , Datuk Zulkarnain Md Eusope , Leonard Ariff Abdul Shatar , Drug Control , குவாலா லம்பூர் , அப்துல் சதர் , மருந்து கட்டுப்பாடு அதிகாரம் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , நோய்த்தடுப்பு ப்ரோக்ராம் ,

Health Ministry inks agreements with vaccine suppliers


Health Ministry inks agreements with vaccine suppliers
January 26, 2021
KUALA LUMPUR – The Ministry of Health (MOH) today signed term sheet agreements with two vaccine suppliers, Pharmaniaga Lifescience Sdn Bhd (PLS) and Duopharma (M) Sdn Bhd for the procurement of 18.4 million doses of COVID-19 vaccine for 28.75 per cent of the Malaysian population.
MOH, in a statement today said PLS would supply 12 million doses of COVID-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated produced by Sinovac Life Science Co. Ltd, which would be distributed in stages beginning April.
Advertisement
“Duopharma will supply 6.4 million doses of Sputnik V vaccine, produced by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. The vaccine is expected to be distributed in stages by end-March 2021,” it said. ....

Kuala Lumpur , Kem Bina Negara , Abdul Shatar , Duopharmam Sdn Bhd , Adham Baba , Pharmaniaga Lifescience Sdn Bhd , Royal Malaysian Police , National Service Training Programme , National Security Council Emergency Session , Duopharma Biotech Berhad Group , Ministry Of Health , Immunisation Programme , Gamaleya Research Institute Of Epidemiology , Multimedia Ministry , National Pharmaceutical Regulatory Division , Bank Negara Malaysia , Public Service , Drug Control Authority , Health Ministry , Prisons Department , Emergency Management Technical Committee , Sinovac Life Science Co , Sdn Bhd , Vero Cell , Sinovac Life Science , Gamaleya Research Institute ,